文献速递泌尿生殖腹部MR

快速前列腺MRI与常规多参数前列腺MRI的对比及结局

Fast prostate MRI vs. conventional multiparametric prostate MRI: comparison and outcomes.
PubMed 文献 · Abdom Radiol (NY) · 2025-04-07

该IRB批准的回顾性研究纳入2016年1月至2021年5月接受多参数前列腺MRI的100例50–80岁男性,按PI-RADS 1-2、3、4-5分为A、B、C三组;两名放射科医生盲法独立为快速前列腺MRI方案病例分配最高病灶PI-RADS评分,并与多参数MRI、PSA及靶向活检结果比较。快速前列腺MRI与多参数MRI的一致性为0.69(95%CI 0.62–0.75);B或C组合并预测Gleason评分≥7的阳性预测值在多参数MRI、快速方案阅片者1、阅片者2分别为62%(40/64)、67%(40/60)、72%(39/54),阴性预测值分别为100%(3/3)、100%(7/7)、92%(12/13)。作者认为这是一项先导研究,提示可能有必要开展更大规模的前瞻性研究以帮助确立快速前列腺MRI作为前列腺癌筛查工具。

要点

  • 快速前列腺MRI与多参数MRI的总体一致性为0.69(95%CI 0.62–0.75)。
  • B或C组预测Gleason评分≥7的阳性预测值:多参数MRI 62%(40/64),快速方案阅片者1 67%(40/60),阅片者2 72%(39/54)。
  • B或C组预测Gleason评分≥7的阴性预测值:多参数MRI 100%(3/3),阅片者1 100%(7/7),阅片者2 92%(12/13)。

核心结论

  • 快速前列腺MRI与多参数MRI在B组和C组的总体一致性、阳性预测值和阴性预测值分别为中等偏高、中等偏高和非常高。

研究设计与样本

  • IRB批准的回顾性研究,纳入2016年1月至2021年5月接受多参数前列腺MRI的100例50–80岁男性,按PI-RADS 1-2(A组)、PI-RADS 3(B组)、PI-RADS 4-5(C组)分组。

诊断标准与关键数值

  • 两名盲法放射科医生独立为每个快速前列腺MRI病例分配最高病灶PI-RADS评分。
  • 快速前列腺MRI两名阅片者与多参数MRI在A、B、C各组的总体一致性为0.69(95%CI 0.62–0.75)。
  • B或C组合并预测Gleason评分≥7的阳性预测值:多参数MRI 62%(40/64;95%CI 0.50–0.74),快速方案阅片者1 67%(40/60;95%CI 0.53–0.78),快速方案阅片者2 72%(39/54;95%CI 0.58–0.84)。
  • B或C组合并预测Gleason评分≥7的阴性预测值:多参数MRI 100%(3/3;95%CI 29–100%),快速方案阅片者1 100%(7/7;95%CI 59–100%),快速方案阅片者2 92%(12/13;95%CI 64–100%)。

临床应用与阅片要点

  • 作者认为这项先导研究提示,可能有必要开展更大规模的前瞻性研究,以帮助确立快速前列腺MRI作为前列腺癌筛查工具。

局限性

  • 作者称本研究为先导研究,并提示可能有必要开展更大规模的前瞻性研究以帮助确立快速前列腺MRI作为前列腺癌筛查工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the overall concordance of a fast prostate MRI (fpMRI) protocol versus conventional multiparametric prostate MRI (mpMRI) protocol.

METHODS: This is an IRB approved retrospective review of 100 men between the ages of 50 and 80 who underwent mpMRI exams from January 2016 to May 2021. The mpMRI exams selected came from three categories: Group A (PI-RADS 1-2); Group B (PI-RADS 3); and Group C (PI-RADS 4-5). Two masked radiologists independently reviewed and assigned each fpMRI case the highest possible lesion PI-RADS score. The collected fpMRI scores were then compared to the mpMRI results, PSA values, and available targeted biopsy outcomes.

RESULTS: The concordance rates between the two fpMRI reviewers and mpMRI for the individually assessed groups (A, B, C) were 0.69 (95% CI,0.62 to 0.75). The PPV of groups B or C combined for GS ≥ 7 for mpMRI, R1 fpMRI, and R2 fpMRI was 62% (40/64; 95% CI,0.50 to 0.74), 67% (40/60; 95% CI,0.53 to 0.78), and 72% (39/54; 95% CI,0.58 to 0.84), respectively. The negative predictive value (NPV) of group B or C combined for GS ≥ 7 on mpMRI, R1 fpMRI, and R2 fpMRI was 100% (3/3; 95% CI,29 to 100%), 100% (7/7; 95% CI,59 to 100%), and 92% (12/13; 95% CI,64 to 100%), respectively.

CONCLUSIONS: The concordance rates, PPV and NPV between the mpMRI and fpMRI results for groups B and C were moderately high, moderately high, and very high, respectively. This pilot study suggests that a larger prospective study might be beneficial to help establish fpMRI as a screening tool for prostate cancer.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Kordbacheh H, Ristic G, Heath E, et al. Fast prostate MRI vs. conventional multiparametric prostate MRI: comparison and outcomes. Abdom Radiol (NY). 2025. PMID: 40192812. doi:10.1007/s00261-025-04918-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。